References
- Balen AH, Laven JS, Tan SL, Dewailly D. 2003. Ultrasound assessment of the polycystic ovary: international consensus definitions. Human Reproduction Update 9:505–514.
- Bar-Or D, Rael LT, Bar-Or R, Slone DS, Mains CW Rao NK, et al. 2008. The cobalt-albumin binding assay: insights into its mode of action. Clinica Chimica Acta 387:120–127.
- Caglar GS, Oztas E, Karadag D, Pabuccu R, Demirtas S. 2011. Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance. Fertility and Sterility 95:310–313.
- Cakir E, Ozbek M, Ozkaya E, Colak N, Cakal E Sayki M, et al. 2011. Oxidative stress markers are not valuable markers in lean and early age of polycystic ovary syndrome patients. Journal of Endocrinology Investigation 34:e178–e182.
- Cascella T, Palomba S, De Sio I, Manguso F, Giallauria F De Simone B, et al. 2008. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome. Human Reproduction 23:153–159.
- Economou F, Xyrafis X, Livadas S, Androulakis II, Argyrakopoulou G Christakou CD, et al. 2009. In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls. Hormones (Athens) 8:199–206.
- Escobar-Morreale HF, San Millan JL. 2007. Abdominal adiposity and the polycystic ovary syndrome. Trends in Endocrinology Metabolism 18:266–272.
- Gaze DC. 2009. Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia. Drug Metabolism and Pharmacokinetics 24:333–341.
- Gonzalez F, Rote NS, Minium J, Kirwan JP. 2006. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. Journal of Clinical Endocrinology Metabolism 91:336–340.
- Goumenou AG, Matalliotakis IM, Koumantakis GE, Panidis DK. 2003. The role of leptin in fertility. European Journal of Obstetrics & Gynecology and Reproductive Biology 106:118–124.
- Guven S, Karahan SC, Bayram C, Ucar U, Ozeren M. 2009. Elevated concentrations of serum ischaemia-modified albumin in PCOS, a novel ischaemia marker of coronary artery disease. Reproductive Biomedicine Online 19:493–500.
- Hu W, Qiao J, Yang Y, Wang L, Li R. 2011. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology 157:53–56.
- Jo SK, Lee WY, Rhee EJ, Won JC, Jung CH Park CY, et al. 2009. Serum gamma-glutamyl transferase activity predicts future development of metabolic syndrome defined by 2 different criteria. Clinica Chimica Acta 403:234–240.
- Lee DH, Blomhoff R, Jacobs DR. Jr. 2004. Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radical Research 38:535–539.
- Lee DH, Jacobs DR. Jr. 2005. Association between serum gamma-glutamyl transferase and C-reactive protein. Atherosclerosis 178:327–330.
- March WA, Moore VM, Willson KJ, Phillips DI, Norman RJ, Davies MJ. 2010. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction 25:544–551.
- Nemesanszky E, Lott JA. 1985. Gamma-glutamyl transferase and its isoenzymes: progress and problems. Clinical Chemistry 31:797–803.
- Norman RJ, Dewailly D, Legro RS, Hickey TE. 2007. Polycystic ovary syndrome. The Lancet 370:685–697.
- Perry IJ, Wannamethee SG, Shaper AG. 1998. Prospective study of serum gamma-glutamyl transferase and risk of NIDDM. Diabetes Care 21:732–737.
- Prefumo F, Gaze DC, Papageorghiou AT, Collinson PO, Thilaganathan B. 2007. First trimester maternal serum ischemia modified albumin: a marker of hypoxia ischemia–driven early trophoblast development. Human Reproduction 22:2029–2032.
- Preiss D, Sattar N, Harborne L, Norman J, Fleming R. 2008. The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome. International Journal of Clinical Practice 62:1337–1343.
- Repaci A, Gambineri A, Pasquali R. 2011. The role of low-grade inflammation in the polycystic ovary syndrome. Molecular Cell Endocrinology 335:30–41.
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility 81:19–25.
- Samy N, Hashim M, Sayed M, Said M. 2009. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Disease Markers 26:163–170.
- Thathapudi S, Kodati V, Erukkambattu J, Katragadda A, Addepally U, Hasan Q. 2014. Anthropometric and biochemical characteristics of polycystic ovarian syndrome in south Indian women using AES-2006 criteria. International Journal of Endocrinology Metabolism 12:e12470.
- Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. Journal of Clinical Investigation 112:1796–1808.
- Whitfield JB. 2001. Gamma glutamyl transferase. Critical Reviews in Clinical Laboratory Science 38:263–355.
- Yildirim B, Sabir N, Kaleli B. 2003. Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome. Fertility and Sterility 79:1358–1364.